Lactylation-related lncRNAs can forecast prognosis and immune response of lung adenocarcinoma
Abstract Background Lung adenocarcinoma (LUAD) represents a significant proportion of lung cancer cases, with immunotherapy serving as a cornerstone of treatment. Although immunotherapy has advanced significantly, the prognosis for patients in advanced stages remains suboptimal. Lactylation, a newly...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer
2025-12-01
|
| Saila: | Discover Oncology |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1007/s12672-025-04306-0 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|